Journal article
Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis The Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial
Abstract
BACKGROUND: Aortic stenosis (AS) is a common health problem in the western world. Recent studies have suggested that cholesterol lowering may have a salutary effect on the progression of AS. The primary objective of the ASTRONOMER study is to determine whether patients with AS randomized to rosuvastatin will experience less progression in AS severity as measured by aortic transvalvular gradients and valve areas. The secondary objectives are to …
Authors
Chan K-L; Teo K; Tam J; Dumesnil JG; Investigators FTA
Journal
American Heart Journal, Vol. 153, No. 6, pp. 925–931
Publisher
Elsevier
Publication Date
6 2007
DOI
10.1016/j.ahj.2007.03.011
ISSN
0002-8703
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAnticholesteremic AgentsAortic ValveAortic Valve StenosisDisease ProgressionDouble-Blind MethodEchocardiographyFemaleFluorobenzenesFollow-Up StudiesHeart Valve ProsthesisHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPatient SelectionPyrimidinesRandomized Controlled Trials as TopicResearch DesignRosuvastatin CalciumSulfonamidesSurvival RateTreatment Outcome